These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19211200)

  • 1. Capecitabine initially concomitant to radiotherapy then perioperatively administered in locally advanced rectal cancer.
    Zampino MG; Magni E; Leonardi MC; Petazzi E; Santoro L; Luca F; Chiappa A; Petralia G; Trovato C; Fazio N; Orecchia R; Nolè F; de Braud F
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):421-7. PubMed ID: 19211200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer.
    Krishnan S; Janjan NA; Skibber JM; Rodriguez-Bigas MA; Wolff RA; Das P; Delclos ME; Chang GJ; Hoff PM; Eng C; Brown TD; Crane CH; Feig BW; Morris J; Vadhan-Raj S; Hamilton SR; Lin EH
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):762-71. PubMed ID: 17011451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial.
    Dunst J; Debus J; Rudat V; Wulf J; Budach W; Hoelscher T; Reese T; Mose S; Roedel C; Zuehlke H; Hinke A
    Strahlenther Onkol; 2008 Sep; 184(9):450-6. PubMed ID: 19016023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemoradiotherapy with capecitabine followed by laparoscopic resection in locally advanced tumors of middle and low rectum - toxicity and complications of the treatment.
    Soumarova R; Skrovina M; Bartos J; Gruna J; Wendrinski A; Czudek S; Kycina R; Parvez J
    Eur J Surg Oncol; 2010 Mar; 36(3):251-6. PubMed ID: 19879716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors of tumor response after neoadjuvant chemoradiation for locally advanced rectal cancer.
    Moureau-Zabotto L; Farnault B; de Chaisemartin C; Esterni B; Lelong B; Viret F; Giovannini M; Monges G; Delpero JR; Bories E; Turrini O; Viens P; Salem N
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):483-91. PubMed ID: 21093174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative concomitant boost intensity-modulated radiotherapy with oral capecitabine in locally advanced mid-low rectal cancer: a phase II trial.
    Li JL; Ji JF; Cai Y; Li XF; Li YH; Wu H; Xu B; Dou FY; Li ZY; Bu ZD; Wu AW; Tham IW
    Radiother Oncol; 2012 Jan; 102(1):4-9. PubMed ID: 21903285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II study of cetuximab, capecitabine and radiotherapy in neoadjuvant treatment of patients with locally advanced resectable rectal cancer.
    Velenik V; Ocvirk J; Oblak I; Anderluh F
    Eur J Surg Oncol; 2010 Mar; 36(3):244-50. PubMed ID: 20042310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: a phase II trial.
    Ballonoff A; Kavanagh B; McCarter M; Kane M; Pearlman N; Nash R; Shah RJ; Raben D; Schefter TE
    Am J Clin Oncol; 2008 Jun; 31(3):264-70. PubMed ID: 18525306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative radiotherapy with capecitabine and mitomycin C in locally advanced rectal carcinoma.
    Stojanovic S; Popov I; Radosevic-Jelic L; Micev M; Borojevic N; Nikolic V; Krivokapic Z; Kecmanovic D; Gavrilovic D; Kezic I
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):787-93. PubMed ID: 21188380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer.
    Kim JS; Kim JS; Cho MJ; Song KS; Yoon WH
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):403-8. PubMed ID: 12243814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer.
    Park JH; Yoon SM; Yu CS; Kim JH; Kim TW; Kim JC
    Cancer; 2011 Aug; 117(16):3703-12. PubMed ID: 21328328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative concurrent radiotherapy with capecitabine before total mesorectal excision in locally advanced rectal cancer.
    Kim JC; Kim TW; Kim JH; Yu CS; Kim HC; Chang HM; Ryu MH; Park JH; Ahn SD; Lee SW; Shin SS; Kim JS; Choi EK
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):346-53. PubMed ID: 15913913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer.
    Zhao L; Bai C; Shao Y; Guan M; Jia N; Xiao Y; Qiu H; Zhang F; Yang T; Zhong G; Chen S
    Cancer Lett; 2011 Nov; 310(2):134-9. PubMed ID: 21782322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phase I study of postoperative concurrent chemoradiation with capecitabine as adjuvant treatment for stage II/III operable rectal cancer].
    Jin J; Li YX; Liu YP; Wang WH; Li T; Li N; Song YW
    Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):393-6. PubMed ID: 17045010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II study of preoperative capecitabine and radiation therapy in patients with rectal cancer.
    Desai SP; El-Rayes BF; Ben-Josef E; Greenson JK; Knol JA; Huang EH; Griffith KA; Philip PA; McGinn CJ; Zalupski MM
    Am J Clin Oncol; 2007 Aug; 30(4):340-5. PubMed ID: 17762432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of capecitabine and oxaliplatin administered prior to and then concomitant to radiotherapy in high risk locally advanced rectal cancer.
    Gao YH; An X; Sun WJ; Cai J; Cai MY; Kong LH; Lin JZ; Liu GC; Tang JH; Wu XJ; Chen G; Pan ZZ; Ding PR
    J Surg Oncol; 2014 Apr; 109(5):478-82. PubMed ID: 24288203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of preoperative pelvic radiation therapy and concomitant boost irradiation in locally advanced rectal cancer patients: a multi-institutional phase II study (KROG 04-01).
    Lee JH; Kim DY; Nam TK; Yoon SC; Lee DS; Park JW; Oh JH; Chang HJ; Yoon MS; Jeong JU; Jang HS
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):955-61. PubMed ID: 22537540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer.
    Chau I; Brown G; Cunningham D; Tait D; Wotherspoon A; Norman AR; Tebbutt N; Hill M; Ross PJ; Massey A; Oates J
    J Clin Oncol; 2006 Feb; 24(4):668-74. PubMed ID: 16446339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative capecitabine with pelvic radiotherapy for locally advanced rectal cancer (phase I trial).
    Veerasarn V; Phromratanapongse P; Lorvidhaya V; Lertsanguansinchai P; Lertbutsayanukul C; Panichevaluk A; Boonnuch W; Chinswangwatanakul V; Lohsiriwat D; Rojanasakul A; Thavichaigarn P; Jivapaisarnpong P
    J Med Assoc Thai; 2006 Nov; 89(11):1874-84. PubMed ID: 17205868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II trial of neoadjuvant capecitabine combined with hyperfractionated accelerated radiation therapy in locally advanced rectal cancer.
    Marsh Rde W; George TJ; Siddiqui T; Mendenhall WM; Zlotecki RA; Grobmyer S; Hochwald S; Chang M; Larson B; King J
    Am J Clin Oncol; 2010 Jun; 33(3):251-6. PubMed ID: 19823074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.